What is XANADU QUANTUM TECHNOLOGIES's earnings per share (EPS)?

XANADU QUANTUM TECHNOLOGIES (XNDU) reported diluted earnings per share of $-12035.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

XANADU QUANTUM TECHNOLOGIES Financials

XNDU

Source SEC Filings (10-K/10-Q) Updated Apr 9, 2026 Currency USD FYE April

This page shows XANADU QUANTUM TECHNOLOGIES (XNDU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 2/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of XANADU QUANTUM TECHNOLOGIES's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity

XANADU QUANTUM TECHNOLOGIES's current ratio of 0.99 is below the typical benchmark, resulting in a score of 15/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$12K

XANADU QUANTUM TECHNOLOGIES reported -$12K in net income in fiscal year 2025.

EPS (Diluted)

$-12035.00

XANADU QUANTUM TECHNOLOGIES earned $-12035.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

255M

XANADU QUANTUM TECHNOLOGIES had 255M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

XNDU Income Statement

Metric	FY25
Revenue	N/A
Cost of Revenue	N/A
Gross Profit	N/A
R&D Expenses	N/A
SG&A Expenses	$12K
Operating Income	-$12K
Interest Expense	N/A
Income Tax	N/A
Net Income	-$12K
EPS (Diluted)	$-12035.00

XNDU Balance Sheet

Metric	FY25
Total Assets	$1.8M
Current Assets	$1.8M
Cash & Equivalents	N/A
Inventory	N/A
Accounts Receivable	N/A
Goodwill	N/A
Total Liabilities	$1.8M
Current Liabilities	$1.8M
Long-Term Debt	N/A
Total Equity	-$12K
Retained Earnings	-$12K

XNDU Financial Ratios

Metric	FY25
Gross Margin	N/A
Operating Margin	N/A
Net Margin	N/A
Return on Equity	N/A
Return on Assets	-0.7%
Current Ratio	0.99
Debt-to-Equity	-151.50
FCF Margin	N/A

Note: Shareholder equity is negative (-$12K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.99), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Is XANADU QUANTUM TECHNOLOGIES profitable?

No, XANADU QUANTUM TECHNOLOGIES (XNDU) reported a net income of -$12K in fiscal year 2025.

What are XANADU QUANTUM TECHNOLOGIES's total assets?

XANADU QUANTUM TECHNOLOGIES (XNDU) had $1.8M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does XANADU QUANTUM TECHNOLOGIES have outstanding?

XANADU QUANTUM TECHNOLOGIES (XNDU) had 255M shares outstanding as of fiscal year 2025.

What is XANADU QUANTUM TECHNOLOGIES's current ratio?

XANADU QUANTUM TECHNOLOGIES (XNDU) had a current ratio of 0.99 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is XANADU QUANTUM TECHNOLOGIES's debt-to-equity ratio?

XANADU QUANTUM TECHNOLOGIES (XNDU) had a debt-to-equity ratio of -151.50 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is XANADU QUANTUM TECHNOLOGIES's return on assets (ROA)?

XANADU QUANTUM TECHNOLOGIES (XNDU) had a return on assets of -0.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is XANADU QUANTUM TECHNOLOGIES's debt-to-equity ratio negative or unusual?

XANADU QUANTUM TECHNOLOGIES (XNDU) has negative shareholder equity of -$12K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is XANADU QUANTUM TECHNOLOGIES?

XANADU QUANTUM TECHNOLOGIES (XNDU) scores 2 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.